CO1 The Health Outcome Analysis of Sintilimab for the First-Line Treatment of Advanced Gastric or Gastroesophageal Junction Adenocarcinoma: According to the Eq-5D-5L
Abstract
Authors
T. Zhou X.T. Wang S. Zhang H.F. Hu Y.X. Li Y.J. Qiu H.K. Sun Y. Cao A.X. Ma H.C. Li